Mirvaso 3 mg/g Gel is a topical treatment containing brimonidine tartrate, designed to reduce persistent facial erythema (redness) associated with rosacea in adults. /Description: Mirvaso Gel contains brimonidine tartrate, an alpha-2 adrenergic agonist that works by constricting dilated blood vessels in the face, thereby reducing redness. It is specifically formulated for adults experiencing persistent (non-transient) facial erythema due to rosacea. The gel is applied once daily and provides visible reduction in redness within a few hours of application. It is for external use only and should not be applied to eyes, mouth, or other mucous membranes. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
